Lyell Immunopharma Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Lyell Immunopharma Inc
TickerLYEL
CIK #0001806952
CUSIP55083R104
SectorLife Sciences - Pharmaceutical Preparations
Address400 East Jamie Court Suite 301, South San Francisco, CA 94080
Source [EDGAR]
CIK Filing 2011 - 2025
[0001806952] 10-K
[0001806952] 10-Q
[0001806952] 3
[0001806952] 4
[0001806952] 8-K
[0001806952] D
[0001806952] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Explore Investments Llc/De Lyell Immunopharma Inc [2025-08-19] 0.0
Gates Frontier LLC Lyell Immunopharma Inc [2025-08-01] 0.0
Foresite Capital Fund IV LP Lyell Immunopharma Inc [2024-10-31] 3.2
BlackRock Inc Lyell Immunopharma Inc [2024-01-29] 5.7
Vanguard Group Inc Lyell Immunopharma Inc [2023-02-09] 5.05
MWG Management Ltd Lyell Immunopharma Inc [2022-02-14] 8.38
Arch Venture Fund IX LP Lyell Immunopharma Inc [2022-02-14] 15.1
Newton PTC Ltd Lyell Immunopharma Inc [2022-02-14] 6.28
Foresite Capital Fund IV LP Lyell Immunopharma Inc [2022-02-11] 5.5
GlaxoSmithKline PLC Lyell Immunopharma Inc [2022-02-10] 12.6
Form 3/4/5 Filer 2011 - 2025
Lyell Immunopharma, Inc.
Newton Charles W.
Seely Lynn
Hill Stephen J.
Lee Gary K.
Crandell Keith
Gillis Steven
ARCH Venture Partners XIII, LLC
Berns Paul L
Nelsen Robert
ARCH Venture Partners XIII, L.P.
ARCH Venture Fund XIII, L.P.
Burow Kristina
ARCH Venture Partners IX Overage, L.P.
ARCH Venture Partners IX, L.P.
ARCH Venture Fund IX, L.P.
ARCH Venture Partners IX, LLC
Bybee Clinton
ARCH Venture Fund IX Overage, L.P.
Meltz Mark A
Bachleda Mark
Shook David
Nabel Elizabeth G
Klausner Richard
Rieflin William JL
Friedman Cathy
Brawley Otis W
Ramachandra Sumant
Lang Matthew
Bishop Hans Edgar
Albertson Tina M.
Thompson Rahsaan
Turner Heather D
Homans Elizabeth
GSK plc
Form 13F Holdings
Firm Period DFND Voting Shares
Arch Venture Management LLC [2025-06-30] SOLE 0 1,820,634
MWG Management Ltd. [2025-06-30] DFND 1,008,116 1,008,116
Foresite Capital Management IV, LLC [2025-06-30] SOLE 800,399 800,399
Orland Properties Ltd [2025-06-30] DFND 754,698 754,698
Decheng Capital LLC [2025-06-30] SOLE 595,466 595,466
Almitas Capital LLC [2025-06-30] SOLE 579,997 579,997
venBio Partners LLC [2025-06-30] SOLE 473,479 473,479
Vanguard Group Inc [2025-06-30] SOLE 0 439,787
Foresite Capital Management V, LLC [2025-06-30] SOLE 406,652 406,652
Price T Rowe Associates Inc /MD/ [2025-06-30] SOLE 296,131 296,131
Alphabet Inc. [2025-06-30] DFND 0 293,256
Citadel Advisors LLC [2025-06-30] DFND 287,273 287,273
HSG Holding Ltd [2025-06-30] DFND 152,299 152,299
BlackRock, Inc. [2025-06-30] SOLE 144,859 144,859
Geode Capital Management LLC [2025-06-30] DFND 103,270 103,270
RBF Capital, LLC [2025-06-30] SOLE 100,000 100,000
Woodline Partners LP [2025-06-30] SOLE 98,425 98,425
MIC Capital Management UK LLP [2025-06-30] SOLE 87,028 87,028
Renaissance Technologies LLC [2025-06-30] SOLE 67,190 67,190
Charles Schwab Investment Management Inc [2025-06-30] SOLE 61,503 61,503
Millennium Management LLC [2025-06-30] SOLE 52,229 52,229
OrbiMed Advisors LLC [2025-06-30] SOLE 51,727 51,727
TD Asset Management Inc [2025-06-30] SOLE 50,232 50,232
Ikarian Capital LLC [2025-06-30] SOLE 43,799 43,799
Takeda Pharmaceutical Co Ltd [2025-06-30] DFND 41,165 41,165
Johnson & Johnson [2025-06-30] DFND 0 41,165
Jacobs Levy Equity Management Inc [2025-06-30] SOLE 39,621 39,621
State Street Corp [2025-06-30] DFND 33,847 33,847
Canada Pension Plan Investment Board [2025-06-30] SOLE 29,411 29,411
Walleye Capital LLC [2025-06-30] SOLE 29,230 29,230
Prev | Page 2 | Next
Terms | Privacy | Guide
tony@aum13f.com